Baker Bros. Capital (GP), LLC Insider Trading $INCY INCYTE CORP

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Baker Bros. Capital (GP), LLC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Baker Bros. Capital (GP), LLC. Baker Bros. Capital (GP), LLC is 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in Diadexus, Inc. ($DDXS) and 10% Owner in ADOLOR CORP ($ADLR) and Director in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).

Baker Bros. Capital (GP), LLC in INCYTE CORP

Trading Symbol: INCY
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Baker Bros. Capital (GP), LLC: Director
Holdings: 227,594 shares
Current Value: $26,897,059
Latest Transaction: Jul 05 2011
$INCY Market Capitalization: $23.12B
$INCY Previous Close: $118.18

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Baker Bros. Capital (GP), LLC in INCYTE CORP

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ADLR, IBPI, AUXL, BCRX, DDXS, GHDX, HRTX, INCY, SGEN, GEVA

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jul 05 2011	INCY	INCYTE CORP	Baker Bros. Capital (GP), LLC	Director	Sell	J	0.00	11,664	0	227,594	239.3 K to 227.6 K (-4.88 %)

Page: 1